Actively Recruiting
Defining Retinal Structures Using Hyperspectral Retinal Imaging
Led by Center for Eye Research Australia · Updated on 2026-04-29
1000
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates hyperspectral retinal imaging as a novel, non-invasive imaging technique to characterise retinal and optic nerve structures in healthy individuals and patients with eye disease. Hyperspectral imaging captures retinal data across multiple wavelengths to generate detailed spectral information that may reveal features not visible with conventional retinal photography. Approximately 1000 participants will undergo multi-modal ophthalmic imaging in Melbourne, Australia, including hyperspectral imaging, OCT, fundus photography, and related tests. The study aims to compare hyperspectral imaging with standard imaging methods and assess its ability to identify retinal biomarkers associated with diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration.
CONDITIONS
Official Title
Defining Retinal Structures Using Hyperspectral Retinal Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and older
- Able to provide informed consent
- Willing and able to attend a study visit at the Centre for Eye Research Australia
- Participants with diagnosed retinal or optic nerve disease (e.g., diabetic retinopathy, glaucoma, age-related macular degeneration)
- Age- and sex-matched healthy control participants without known retinal or optic nerve disease
You will not qualify if you...
- Inability to provide informed consent
- Ocular conditions preventing adequate retinal imaging (e.g., dense cataract, severe corneal opacity, vitreous haemorrhage)
- Known contraindication to pharmacological pupil dilation
- History of narrow anterior chamber angle or risk of angle closure glaucoma where dilation is considered unsafe
- Any condition that, in the investigator's opinion, would compromise participant safety or image quality
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Centre for Eye Research Australia
Melbourne, Victoria, Australia, 3002
Actively Recruiting
Research Team
D
Darvy Dang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here